Adam Havey, EVP, Business Operations at Emergent BioSolutions Inc. (EBS), sold 6,086 shares at $57.92 ($354K) on 2019-02-28, disclosed to the SEC on 2019-03-04.
Seasonal sale ($354k) by EVP, Business Operations — this insider has traded EBS in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.92 | 1,019 | $59K | 16.7% |
| 2 | $57.92 | 1,019 | $59K | 16.7% |
| 3 | $58.20 | 2,024 | $118K | 33.3% |
| 4 | $58.20 | 2,024 | $118K | 33.3% |
| Total | $58.11 avg | 6,086 | $354K | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2018-11-05 | $653K | — | Filing → |